SerImmune provides a view of how the body responds to pathogens and other environmental factors.
SerImmune is an immune intelligence company that provides a view of immunity and how the body responds to pathogens and other environmental factors in disease and health. The information the company provides fuels the development of new diagnostics, vaccines, and therapeutics. SerImmune’s Immune Information Technology reveals the many antigens that determine functional immune repertoires. The many distinct antibodies within a repertoire can be mapped to antigens from infections, allergens, microbiome organisms, autoimmune diseases, and cancers.SerImmune was founded in 2014 and is headquartered in Goleta, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 21, 2017 | Series A | $8M | 1 | — | — | Detail |